Current status of biologics in severe asthma management
| Further understanding is needed on how and when to switch from one biological therapy to another |
| There is still no consensus on the appropriate length of waiting time before a patient is classified as a non-responder |
| The efficacy of biologics in severe asthma has been demonstrated in a number of trials in recent years, but further research is needed to understand the long-term effects of biological therapy |
| Several clinical studies have demonstrated the oral corticosteroid-sparing effect of biologics |